Rdt Gtfcc 4.17.18

Rdt Gtfcc 4.17.18

Laboratory evaluation of immunochromatographic rapid diagnostic tests for cholera in Haiti WR. Matias, FE. Julceus, C. Abelard, LM. Mayo-Smith, MF. Franke, JB. Harris, LC. Ivers PLoS ONE 12(11), Nov 2017: e0186710 HAITI. CATCHMENT DISTRICTS Haiti PETITE RIVIERE DE L’ARTIBONITE HÔPITAL CHARLES CERCA LA COLIMON HÔPITAL SAINT- HÔPITAL SAINTE-THÉRESÈ SOURCE (PETITE RIVIÈRE) + Centre de Sante de NICOLAS AND SSPE (HINCHE) H Cerca-la-Source +H de SAINT-MARC H HINCHE SAINT- HÔPITAL DUMARSAIS H ESTIMÉ (VERETTES) MARC + THOMONDE BOUCAN Centre de Sante VERETTES de Thomonde CARRE HÔPITAL BON BELLADERE + H SAUVEUR Centre de Sante Saint Michel (CANGE) Centre de Sante de HÔPITAL NOTRE SAUT-D’EAU Lacolline and Clinique H H Sante Fanm + DAME de la HÔPITAL UNIVERSITAIRE NATIVITÉ de MIREBALAIS (BELLADÈRE) SAVANETTE Port-au-Prince MIREBALAIS LASCAHOBAS PIH/ZL Supported District Capital City H PIH/ZL Supported Hospital Health Center HAITI. CATCHMENT DISTRICTS Haiti SUSPECT CHOLERA CASES, HAITI 2010-2017 400000 PETITE 350000 352033 RIVIERE DE L’ARTIBONITE HÔPITAL CHARLES CERCA LA COLIMON HÔPITAL SAINT- HÔPITAL SAINTE-THÉRESÈ SOURCE (PETITE RIVIÈRE) + Centre de Sante de NICOLAS AND SSPE (HINCHE) H Cerca-la-Source +H 300000 de SAINT-MARC H HINCHE SAINT- HÔPITAL DUMARSAIS H ESTIMÉ (VERETTES) MARC + THOMONDE BOUCAN Centre de Sante VERETTES de Thomonde CARRE HÔPITAL BON BELLADERE + H SAUVEUR 250000 Centre de Sante Saint Michel (CANGE) Centre de Sante de HÔPITAL NOTRE SAUT-D’EAU Lacolline and Clinique H H Sante Fanm + DAME de la HÔPITAL UNIVERSITAIRE NATIVITÉ 200000 de MIREBALAIS (BELLADÈRE) 185351 SAVANETTE Port-au-Prince MIREBALAIS 150000 LASCAHOBAS 100000 101503 Study 58574 50000 41421 27392 36045 13681 0 2010 2011 2012 2013 2014 2015 2016 2017 PIH/ZL Supported District Capital City H PIH/ZL Supported Hospital Health Center Crystal VC Dipstick Sensitivity: 88 – 100% Span Diagnostics, Ltd., India Specificity : 61 – 87.3% Artron Vibrio Cholerae O139 and Sensitivity: 99% O1 Combo Test Specificity : 99% Artron Laboratories. Inc., Canada Never field tested Rapid tests in Haiti SD Bioline Cholera Ag O1/O139 Sensitivity : 95.4% RDT Standard Diagnostics Inc., Specificity: 94.1% South Korea Never field tested Study Design • Retrospective review of ordinarily Alkaline Peptone Water (APW) collected laboratory surveillance May, 2014 - May, 2015 records • plated directly onto TCBS without • May 2014 to October 2015 enrichment in APW. • Cases - acute watery diarrhea • Rapid diagnostic testing End May - Oct, 2015 • Bacterial culture • enriched in APW for 6 hours prior • processed immediately, or • stored in Cary Blair (Becton, Dickinson and Co., to plating on TCBS Maryland, USA) transport medium at 2-8C and processed within a week. • Trained laboratory technicians Results Test Total Positive Negative Positivity Rate Culture 905 477* 428 52.7% Crystal VC 511 347 164 67.9% Artron 129 90 39 69.8% SD Bioline 451 212 239 47.0% *345 Ogawa (72.3%); 132 Inaba (27.7%) RDT Performance Characteristics for V. cholerae O1 Test Sensitivity Specificity Positive Predictive Value Negative Predictive Value [95% CI] [95% CI] [95% CI] [95% CI] 98.6% 71.1% 81.3% 97.6% Crystal VC (96.5 –99.6%) (64.7 – 76.9%) (76.8 – 85.2%) (93.9 – 99.3%) 98.6% 69.1% 81.1% 97.4% Artron (92.7 – 100.0%) (55.2 – 80.9%) (71.5 – 88.6%) (86.5 – 99.9%) 81.1% 92.8% 92.9% 80.8% SD Bioline (75.6 – 85.8%) (88.4 – 95.9%) (88.6 – 96.0%) (75.2 – 85.6%) RDT Performance Characteristics for V. cholerae O1 Test Sensitivity Specificity Positive Predictive Value Negative Predictive Value [95% CI] [95% CI] [95% CI] [95% CI] 98.6% 71.1% 81.3% 97.6% Crystal VC (96.5 –99.6%) (64.7 – 76.9%) (76.8 – 85.2%) (93.9 – 99.3%) 98.6% 69.1% 81.1% 97.4% Artron (92.7 – 100.0%) (55.2 – 80.9%) (71.5 – 88.6%) (86.5 – 99.9%) 81.1% 92.8% 92.9% 80.8% SD Bioline (75.6 – 85.8%) (88.4 – 95.9%) (88.6 – 96.0%) (75.2 – 85.6%) O139 False Positives Crystal VC and Artron RDTs • Crystal VC RDT • 511 total tests • 129 O1, O139 (25.2%) • 26 O139 (5.1%) • Artron RDT • 129 total tests • 9 O1, O139 (7.0%) • 3 O139 (2.3%) • No O139 Positive bands were detected with SD Bioline RDT • Only 1 Vibrio cholerae O139 had been isolated in Haiti Conclusions • Limitations • Retrospective • Culture as gold standard • Performance characteristics of Crystal VC, Artron, and SDBioline RDTs are suboptimal • Use in outbreak identification • Use in formal surveillance activities • Frequent false O139 positives with Crystal VC and Artron RDTs Thank you - Partners In Health (PIH) - Zanmi Lasante (ZL) - Ministère de la Santé Publique et de la Population - l'Hôpital Saint Nicolas de Saint Marc - Massachusetts General Hospital - Harvard Medical School Department of Global Health and Social Medicine - The Doris Duke Foundation - National Institutes of Health - Madison Family Fund - The Bill and Melinda Gates Foundation Supporting Table 1. Positivity Rates for Bacterial Culture and 3 RDTs for detection of V. cholerae O1. Without APW enrichment With APW enrichment Grouped Test Total Positive Negative Positivity Total Positive Negative Positivity Total Positive Negativ Positivity Rate (%) Rate (%) e Rate (%) Culture 450 234 216 52.0 455 243 212 53.4 905 477 428 52.7 VC 349 239 110 68.5 162 108 54 66.7 511 347 164 67.9 Art 9 5 4 55.6 120 85 35 70.8 129 90 39 69.8 SD 428 204 224 47.7 23 8 15 34.8 451 212 239 47.0 Supporting Table 2. Number of Specimens tested by different combinations of RDTs. *VC = Crystal VC; SD = SD Bioline; Art = Artron VC VC + SD VC + Art VC + SD + SD SD + Art Art Art 19 363 120 9 79 0 0 • Isolation on TCBS, biochemical testing with oxidase and string test, serological confirmation with O1/O139 and Ogawa/Inaba antisera.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    13 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us